Unlicensed “Special” Medicines: Understanding the Community Pharmacist Perspective
Alesha Wale,1 Mark Ireland,2 Rowan Yemm,1 Sarah Hiom,3 Alison Jones,3 John Paul Spark,3 Mark Francis,4 Karen May,5 Louise Allen,5 Steve Ridd,6 Efi Mantzourani1,7 1School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales, UK; 2Community Pharmacy Wales, Cardiff, Wales, UK; 3S...
Main Authors: | Wale A, Ireland M, Yemm R, Hiom S, Jones A, Spark JP, Francis M, May K, Allen L, Ridd S, Mantzourani E |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-08-01
|
Series: | Integrated Pharmacy Research and Practice |
Subjects: | |
Online Access: | https://www.dovepress.com/unlicensed-ldquospecialrdquo-medicines-understanding-the-community-pha-peer-reviewed-article-IPRP |
Similar Items
-
Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: a systematic review
by: Fábio Reis, et al.
Published: (2021-07-01) -
Off-label and unlicensed drug use in a Spanish Neonatal Intensive Care Unit
by: Belén Cabezuelo Escribano, et al.
Published: (2017-05-01) -
Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit
by: Meles Tekie Gidey, et al.
Published: (2020-04-01) -
Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran
by: Leila Kouti, et al.
Published: (2019-01-01) -
OFF-LABEL PRESCRIBING. POSSIBLE CAUSES, TYPES AND CONSEQUENCES. LEGAL REGULATION IN THE RUSSIAN FEDERATION
by: S. Yu. Martsevich, et al.
Published: (2017-11-01)